MENU
CTMX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
CytomX Therapeutics (CTMX) Ownership - Who owns CytomX Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
151 Oyster Point Boulevard
Phone
+1 650 515-3185
Employees
122
Web
https://www.cytomx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
85.3M
P/E Ratio
6.81
Total Cash
117.59M
Projected Growth
N/A
Total Debt
10.6M
Revenue
126.62M
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash/Share
1.50
Total Debt/Equity
N/A
Revenue/Share
1.51 USD as % of share price
Fundamentals
CTMX
Capitalization
85.3M
P/E Ratio
6.81
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash
118M
Total Cash/Share
1.50
Total Debt
10.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.51%
Revenue
127M
ROE
N/A
Book Value
-23.45M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
0.16
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
1.04
Current Revenue Per Employee
274032.78
Dividends Per Share - Security
N/A
EBITDA
8.55M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
7.68
Shares Held By Institutions
63.6M
Shares Outstanding - Current
78.3M
Total Liabilities
162M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-29.677
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
151 Oyster Point Boulevard
Phone
+1 650 515-3185
Employees
122
Web
https://www.cytomx.com